Table 1 Characteristics of glioma patients and healthy controls
From: Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis
Characteristics | Cases (n = 575) | Controls (n = 500) | p | |
|---|---|---|---|---|
Age, years | Mean ± SD (year) | 40.53 ± 13.90 | 40.45 ± 18.08 | 0.942a |
≤ 40 | 279 (49%) | 265 (53%) | ||
> 40 | 296 (51%) | 235 (47%) | ||
Gender | 1.000b | |||
Male | 320 (56%) | 279 (56%) | ||
Female | 255 (44%) | 221 (44%) | ||
WHO grade | I-II | 369 (64%) | ||
III-IV | 206 (36%) | |||
astrocytoma | 448 (78%) | |||
Surgical method | STR & NTR | 184 (32%) | ||
GTR | 394 (68%) | |||
Radiotherapy | Gamma knife | 365 (63%) | ||
Conformal radiotherapy | 156 (27%) | |||
No | 57 (10%) | |||
Chemotherapy | Yes | 237 (41%) | ||
No | 341 (59%) | |||
State of progress | Progress | 538 (93%) | ||
No | 35 (6%) | |||
Absent | 5 (1%) | |||